This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on March 8, 2021.

Return to the list of Patented Medicine Litigation page.

---

---

Sitagliptin

JANUMET, JANUMET XR, JANUMETXR, JANUVIA – Merck Canada Inc. (NOC Search)

Patents:

• 2416786: SANDOZ
• 2416794: SANDOZ
• 2416808: SANDOZ
• 2450740: TEVA, REDDY, SANDOZ, JAMP
• 2518435: REDDY, TEVA, SANDOZ
• 2529400: REDDY, TEVA, SANDOZ
• 2536251: SANDOZ, REDDY, TEVA

APOTEX

• PM(NOC) – T-560-20 – T-561-20 – T-563-20 – T-601-20 – T-602-20 – T-665-20 – T-666-20

JAMP

• PM(NOC) – T-1187-20 – T-667-20 – T-668-20 – T-672-20

PHARMASCIENCE

• PM(NOC) – T-419-20 – T-673-20

REDDY

• PM(NOC) – T-249-21 – T-250-21 – T-251-21 – T-252-21

SANDOZ

• Infringement – T-415-21 – T-5-21 – T-6-21
• PM(NOC) – T-418-20 – T-670-20 (2020 FC 1180)

TEVA

• PM(NOC) – T-188-21 – T-190-21 – T-253-21 – T-254-21

---

Return to the Patented Medicine Litigation page.